Bioventus Inc.
Bioventus Inc. (BVS) Revenue
Annual & quarterly revenue history · segment & region breakdown
BVS · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsBioventus Inc. trailing twelve-month (TTM) revenue is $0.58B, a decrease of 0.91% year-over-year from $0.57B in FY2025.
Revenue trend
2025 – 2013 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.57B | -$0.01B | -0.91% |
| 2024-12-31 | $0.57B | +$0.06B | +11.89% |
| 2023-12-31 | $0.51B | +$0.00B | +0.04% |
| 2022-12-31 | $0.51B | +$0.08B | +18.85% |
| 2021-12-31 | $0.43B | +$0.11B | +34.17% |
| 2020-12-31 | $0.32B | -$0.02B | -5.58% |
| 2019-12-31 | $0.34B | +$0.02B | +6.57% |
| 2018-12-31 | $0.32B | +$0.03B | +9.29% |
| 2017-12-31 | $0.29B | +$0.02B | +6.40% |
| 2016-12-31 | $0.27B | +$0.02B | +8.22% |
Compare revenue vs peers
Medical - DevicesCompare BVS revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Bioventus Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Bioventus Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Bioventus Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
BVS revenue · 4 questionsBVS's trailing twelve-month (TTM) revenue is $0.58B. That is a decrease of 0.91% year-over-year from $0.57B in FY2025.
▸ Source: FMP · Bioventus Inc. SEC filings · GAAP · Bioventus Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026